Sodium 3-(benzothiazol-2-ylthio)-1-propanesulfonate, 99.0%, 5g

5-?Bromo-?3-?chloro-2-?thiophenemethanol, 98%, 5g

GC capillary column ROTI®Cap-5 MS Ultra, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

2-[(6-Methoxy-2-methylsulfanyl-pyrimidin-4-ylamino)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg

5-(Trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid, 95.0%, 5g

2-(2-Chloroethylamino)-4,6-dimethylnicotinonitrile, 95.0%, 5g

Iohexol (mixture of isomers)>98.0%(HPLC)(N)5g

(S)-(-)-1,1,2-Triphenyl-1,2-ethanediol1g

(5-Fluoropyrimidin-2-yl)acetic acid, 95.0%, 250mg

2-(tert-Butylamino)acetic acid hydrochloride, 95.0%, 500g

2-Methoxy-4-pyridinecarboxylic acid, 98.0%, 100g

2-Aminoethanol, 99.0%, 1kg

6-Butylpyrimidine-2,4(1H,3H)-dione, 97%, 250mg